Mirae Asset Global Investments
XERS icon

Mirae Asset Global Investments’s Xeris Biopharma Holdings XERS Stock Holding History

Mirae Asset Global Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.1K Sell
7,721
-934
-11% -$5.96K ﹤0.01% 1329
2026
Q1 		$50.2K Buy
8,655
+592
+7% +$3.92K ﹤0.01% 1296
2025
Q4 		$63.3K Buy
8,063
+1,820
+29% +$14.3K ﹤0.01% 1348
2025
Q3 		$50.8K Buy
6,243
+56
+0.9% +$372 ﹤0.01% 1338
2025
Q2 		$28.9K Buy
6,187
+1,199
+24% +$5.49K ﹤0.01% 1344
2025
Q1 		$27.8K Buy
4,988
+20
+0.4% +$81 ﹤0.01% 1344
2024
Q4 		$17K Sell
4,968
-421
-8% -$1.35K ﹤0.01% 1441
2024
Q3 		$15.5K Buy
5,389
+963
+22% +$2.47K ﹤0.01% 1463
2024
Q2 		$10K Buy
+4,426
New +$8.92K ﹤0.01% 1465

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Mirae Asset Global Investments's XERS Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Xeris Biopharma Holdings (XERS) stake by 11% in Q2 2026, selling an estimated $5.96K and leaving 7,721 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Mirae Asset Global Investments first reported a position in XERS in Q2 2024 and has held it in 9 quarters since. The position peaked at $63.3K in Q4 2025. 78 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Mirae Asset Global Investments held 7,721 shares of Xeris Biopharma Holdings worth $61.1K as of Q2 2026.
  • Mirae Asset Global Investments sold 934 Xeris Biopharma Holdings shares in Q2 2026, an estimated $5.96K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1329 holding.
  • Mirae Asset Global Investments first reported a position in Xeris Biopharma Holdings in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Xeris Biopharma Holdings position peaked at $63.3K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.